Sanofi Consumer Healthcare India listed on BSE and NSE
SCHIL marks a milestone with listing following demerger from Sanofi India
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
bse
Akums Pharma’s IPO to open on July 30, 2024
Price Band fixed at ₹ 646 to ₹ 679 per equity share of face value of ₹ 2 each
Indian shares rise one per cent lifted by pharma
Indian shares ended up one per cent yesterday in broad-based buying, led by a surge in pharma stocks, even as global markets…
Cipla Q1 net profit rises 25 per cent to Rs 709.92 crores
The company had posted a net profit of Rs 566.04 crores in the corresponding period of the previous fiscal, Cipla said in a filing…
US FDA cautions Aurobindo Pharma’s oral solids formulation facility of regulatory action
According to US FDA's definitions, OAI means "objectionable conditions were found and regulatory administrative sanctions by FDA…
US FDA issues three observations to Ipca Laboratories Silvassa unit
In regulatory filing to BSE, Ipca Laboratories said US FDA conducted inspection of its formulations manufacturing unit from from…
Strides announces final closure of Arrow transaction
According to the statement filed by the company with BSE, all proceeds net of transaction cost will be used to pare down debt
Aurobindo Pharma gets warning letter from US FDA for Andhra Pradesh unit
The company received a warning letter from the United States Food and Drug Administration (US FDA) related to their unit XI,…
Dishman Pharma board gives nod to amalgamation, bonus issue
The board has also given nod to amalgamation of the firm with Carbogen Amcis India Ltd Drug firm Dishman Pharmaceuticals and…
Aurobindo Pharma gets shareholders’ nod to raise up to $600 million
The funds will facilitate and meet the additional capital expenditure requirements for the ongoing and future projects of the…